On 14 July 2017, Eli Lilly & Company (Lilly) celebrated 50 years of pioneering research and development at its site in Erl Wood (Surrey, UK). The Lilly Research Centre was established in 1967 and has played a key role in some of the company's most important scientific breakthroughs, including the discovery of olanzapine (Zyprexa") for the treatment of schizophrenia and bipolar disorders. Launched in 1996, olanzapine became Lilly's most successful medicine and has been used to treat millions of patients worldwide. Over 600 people, representing 45 nationalities and 30 different functional disciplines, continue to collaborate from Erl Wood on the discovery and development of new medicines to meet areas of major unmet medical need.
展开▼
